ClinicalTrials.Veeva

Menu
A

Altus Research | Women's Health Studies

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Estradiol
Fluconazole
Elagolix
fezolinetant
Norethindrone Acetate
Mesafem
SCY-078
VT-1161
Dexmecamylamine
Oxybutynin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their siteā€™s profile, add contact information, and more.

Learn more and claim site

Active trials

11 of 67 total trials

A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab (ADapt)

The study will assess the safety and efficacy of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD) pre...

Active, not recruiting
Atopic Dermatitis
Drug: Lebrikizumab

The primary objective of this study is to assess the effect of enobosarm on total lean mass as measured by DEXA in patients maintained on GLP-1 recep...

Active, not recruiting
Obesity
Muscle Loss
Drug: Semaglutide
Drug: Enobosarm

This study will be in two parts, Part A and Part B. The primary objective of Part A is to evaluate the contraceptive efficacy of LPRI-CF113. The seco...

Active, not recruiting
Contraception
Change in Bone Mineral Density
Drug: Drospirenone

This is a two-part study designed to evaluate the effect of Estetrol (E4) 15 or 20 mg, or placebo on the severity and frequency of vasomotor symptoms...

Active, not recruiting
Menopausal Symptoms
Vasomotor Symptoms
Drug: Progesterone oral tablet
Drug: Estetrol oral tablet

To assess the contraceptive efficacy (prevention of pregnancy) of VeraCept

Active, not recruiting
Women at Risk for Pregnancy
Drug: VeraCept

Prospective, multi-center, international, non-randomized, two-arm study of subjects undergoing either FemBloc or laparoscopic bilateral tubal sterili...

Active, not recruiting
Contraception
Device: FemBloc
Procedure: Laparoscopic bilateral tubal sterilization

This is an open label, interventional, single arm, multi-clinic study where each adult female participant with stress urinary incontinence (SUI) serv...

Enrolling
Stress Urinary Incontinence
Device: Vaginal pessary

A phase 2 study to assess the efficacy of bimagrumab alone or in addition to semaglutide to assess efficacy and safety in overweight or obese men and...

Active, not recruiting
Overweight or Obesity
Obese
Drug: Semaglutide
Biological: Bimagrumab

Study of the contraceptive efficacy, cycle control, safety, and tolerability of MR-100A-01 in approxmiately 1200 women for up to 13 cycles

Active, not recruiting
Contraception
Drug: MR-100A-01

This study is designed to assess post-procedural outcomes for women who chose to undergo either hysteroscopic sterilization (EssureĀ®) or laparoscopic...

Active, not recruiting
Contraception
Device: ESSURE (BAY1454032)
Procedure: Laparoscopic tubal sterilization

This is a Phase 2, multicenter, randomized, double-blinded, parallel dose group, placebo-controlled, dose-ranging study to evaluate the efficacy and...

Enrolling
Plaque Psoriasis
Drug: TLL018 tablets

Trial sponsors

Pfizer logo
AbbVie logo
Astellas logo
Amgen logo
Bayer logo
C
E
F
Inovio Pharmaceuticals logo
Janssen (J&J Innovative Medicine) logo

Clinical trials

Find clinical trialsTrials by location
Ā© Copyright 2024 Veeva Systems